Scope Biosciences 是一家荷兰公司，专门利用 CRISPR-Cas 开发分子诊断技术。它是瓦赫宁根大学与研究所的衍生公司，由 Jurre Steens、Niek Savelkoul、Bart Scholten 和 Stijn Prinsen 于 2020 年创立。他们得到了经验丰富的企业家 Math Kohnen 和 Wil Hazenberg 的支持。成立 Scope Biosciences 的想法源于与瓦赫宁根大学农业技术与食品科学系微生物实验室的密切合作。Van der Oost 和 Staals 都是共同创始人，并将继续担任科学顾问，为 Scope Biosciences 提供支持。ScopeDx 技术是与瓦赫宁根大学和研究所共同开发的，并独家授权给 Scope Biosciences。

Incorporated in 1997 by its scientific cofounders from the University of Utah, Echelon Biosciences Inc (formerly Echelon Research Laboratories Inc) was a private company which emerged from the Utah Center for Cell Signaling. The company operated under a three-tier strategy, one part of which is involved with the discovery of cell signal modifying, potentially therapeutic molecules. Echelon also focused on small molecule agonists and antagonists to lipid-protein signaling interactions, with early therapeutic leads against ovarian cancer. In January 2005, Echelon was acquired by AEterna Zentaris; however, in November 2007, Echelon was sold to Frontier Scientific,.The company changed its name from Echelon Research Laboratories Inc to Echelon Biosciences Inc in May 2002.The company was located at Salt Lake City, UT. In 2003, Echelon moved into a 12,500 sq ft facility in Utah.In November 2007, AEterna Zentaris sold Echelon to Frontier Scientific, f

Biostate AI是一家位于加利福尼亚州帕洛阿尔托的可扩展生物数据代工厂初创公司，也是RNAstate研究支持平台的开发者，该平台旨在以时间精度预测未来组学状态。该公司的平台使用生成式人工智能来提供分析、见解和可视化，以促进出版物或领导优化决策，使研究机构能够获得负担得起的、可扩展的和有洞察力的生物信息学数据分析。